Initially developed for glycemic control in T2DM, GLP-1 RAs act as incretin mimetics by stimulating glucose-dependent insulin secretion and inhibiting glucagon release (Brunton and Wysham, 2020
This is where the source becomes paramount
Contraindications include a personal or family history of medullary thyroid carcinoma (MTC), multiple endocrine neoplasia syndrome type 2 (MEN 2), or a known allergic reaction to the medication
Always consult a licensed healthcare provider before making decisions about medications or treatment plans
Retatrutide goes a step further by activating three receptors: GIP, GLP-1, and glucagon
Essential supplements during a retatrutide cut: Electrolytes: Sodium, potassium, magnesium